5,6-dihydro-4H-cyclopentathiophene | 7690-98-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 杂芳族化合物
• 英文名称: 5,6-dihydro-4H-cyclopentathiophene
• 英文别名: cyclopenta thiophene；5,6-dihydro-4H-cyclopenta[c]thiophene；4,5,6-trihydro-2-thiapentalene；Cyclopentathiophen；5,6-dihydro-4H-cyclopenta[c]thiophene
• CAS: 7690-98-4
• 化学式: C₇H₈S
• mdl: MFCD18451814
• 分子量: 124.207
• InChiKey: VKSRWASDJSTKRA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.4
• 重原子数：
  8
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.428
• 拓扑面积：
  28.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  5,6-dihydro-4H-cyclopentathiophene 在 正丁基锂 、 二氧化硫 、 sodium acetate 、 hydroxylamine-O-sulfonic acid 作用下， 以 水 为溶剂， 反应 5.33h， 生成 5,6-dihydro-4H-cyclopentathiophene-2-sulfonamide
  参考文献：
  名称：

  Sulfonylureas: a new class of cancer chemotherapeutic agents

  摘要：

  This study summarizes the antitumor properties of a number of sulofenur thiophene analogs against subcutaneously implanted 6C3HED lymphosarcoma with structural modification of the aryl moiety of the sulfonamide portion of the diarylsulfonylureas. The spectrum of activity of N-(p-chlorophenyl)-N'-[(5-methoxy-2-thienyl)sulfonyl]urea in the HXGC3, VRC5, CX-1, and LX-1 cell lines is also presented.

  DOI：

  10.1021/jm00094a013
• 作为产物：
  描述：

  (2,5-dichloro-thiophen-3-ylmethyl)-malonic acid diethyl ester 在 盐酸 、 sodium hydroxide 、 三氯化铝 、 氯化亚砜 、 溶剂黄146 、 肼 、 锌 作用下， 以 乙二醇 为溶剂， 生成 5,6-dihydro-4H-cyclopentathiophene
  参考文献：
  名称：

  Garreau, R.; Roncali, J.; Garnier, F., Journal de Chimie Physique et de Physico-Chimie Biologique, 1989, vol. 86, # 1, p. 93 - 98

  摘要：

  DOI：

文献信息

• FUSED HETEROCYCLIC COMPOUNDS AND THROMBOPOIETIN RECEPTOR ACTIVATORS
  申请人：Shigeta Yukihiro

  公开号：US20120209005A1

  公开（公告）日：2012-08-16

  Fused heterocyclic compounds useful for prevention, treatment or improvement of diseases against which activation of the thrombopoietin receptor is effective are provided. A compound represented by the formula (I) (wherein R 1 is an aryl group fused to a saturated ring or the like, A, B, L 1 , R 2 , L 2 , L 3 , Y, L 4 , R 3 and X are defined in the description), a tautomer, prodrug or a pharmaceutically acceptable salt of the compound or a solvate thereof.

  提供了对激活血小板生成素受体有效的疾病的预防、治疗或改善有用的融合杂环化合物。代表式(I)的化合物（其中R1是与饱和环或类似物融合的芳基，A、B、L1、R2、L2、L3、Y、L4、R3和X在描述中有定义），该化合物的互变异构体、前药或药用可接受的盐或其溶剂化物。
• Thienylalanine derivatives as inhibitors of cell adhesion
  申请人：——

  公开号：US20030105080A1

  公开（公告）日：2003-06-05

  The present invention relates to compounds of formula (I), in which A, B, X, Y, R 1 , R 2 , R 3 and n have the meanings indicated in the claims. The compounds of formula (I) are valuable pharmacologically active compounds. They are vitronectin receptor antagonists and inhibitors of cell adhesion and are suitable for the therapy and prophylaxis of illnesses which are based on the interaction between vitronectin receptors and their ligands in cell-cell or cell-matrix interaction processes or which can be prevented, alleviated or cured by influencing such interactions. For example, they can be applied for inhibiting bone resorption by osteoclasts and thus for treating and preventing osteoporosis, or for inhibiting undesired angiogenesis or proliferation of cells of the vascular smooth musculature. The invention fruthermore relates to processes for the preparation of compounds of formula (I), their use, in particular as active ingredients in pharmaceuticals, and pharmaceutical compositions comprising them.

  本发明涉及式（I）的化合物，其中A、B、X、Y、R1、R2、R3和n具有所述索引中指示的含义。式（I）的化合物是有价值的药理活性化合物。它们是vitronectin受体拮抗剂和细胞黏附抑制剂，适用于基于细胞-细胞或细胞-基质相互作用过程中vitronectin受体和它们的配体之间相互作用的疾病的治疗和预防，或者可以通过影响这些相互作用来预防、缓解或治愈这些疾病。例如，它们可以应用于通过抑制骨吸收细胞破骨细胞来治疗和预防骨质疏松症，或者用于抑制不良血管生成或血管平滑肌细胞增殖。此外，本发明还涉及式（I）的化合物的制备过程，它们的使用，特别是作为药物中的活性成分，以及包含它们的药物组合物。
• 1,1-Disubstituted cycloalkyl derivatives as factor Xa inhibitors
  申请人：——

  公开号：US20040254158A1

  公开（公告）日：2004-12-16

  The present application describes 1,1-disubstituted cycloalkyl compounds and derivatives thereof, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of factor Xa.

  本申请描述了1,1-二取代环烷基化合物及其衍生物，或其药学上可接受的盐形式，这些化合物可用作因子Xa的抑制剂。
• Halogen Substituted Heteroatom-Containing Metallocene Compounds for Olefin Polymerization
  申请人：VOSKOBOYNIKOV Alexander Z.

  公开号：US20120202956A1

  公开（公告）日：2012-08-09

  Halogen substituted metallocene compounds are described and comprise one or more monocyclic or polycyclic ligands that are pi-bonded to the metal atom and include at least one halogen substituent directly bonded to an sp 2 carbon atom at a bondable ring position of the ligand, wherein the or at least one ligand has one or more ring heteroatoms in its cyclic structure. When combined with a suitable activator, these compounds show activity in the polymerization of olefins, such as ethylene and propylene.

  本文描述了卤代金属茂基化合物，包括一个或多个单环或多环配体，这些配体与金属原子π键结合，并在配体的可结合环位置的一个sp2碳原子上直接连接至少一个卤素取代基，其中至少一个配体在其环状结构中具有一个或多个环异原子。当与适当的活化剂结合时，这些化合物表现出在聚合烯烃（如乙烯和丙烯）中的活性。
• New N-heteroarylamide derivatives as inhibitors of acyl coenzyme A: cholestrol acyl transferase
  申请人：PFIZER INC.

  公开号：EP0609960A1

  公开（公告）日：1994-08-10

  Compounds of the formula the pharmaceutically acceptable salts thereof, wherein Q is a substituted pyridine or pyrimidine group and R¹ incorporates a hydrocarbon group of from 4 to 16 carbon atoms, are inhibitors of acyl coenzyme A: cholesterol acyltransferase (ACAT) and are useful as hypolipidemic and antiatherosclerosis agents.

  式中的化合物 其中 Q 是取代的吡啶或嘧啶基团，R¹ 包含 4 至 16 个碳原子的烃基，是酰基辅酶 A：胆固醇酰基转移酶（ACAT）的抑制剂，可用作降血脂药和抗动脉粥样硬化药。